INS and liver disorder: In conclusion, by influencing insulin signaling, fibrogenesis, HSC activation, EMT and cellular plasticity, TGF-β signaling emerges as a pivotal mediator in liver pathogenesis, providing insights into the intricate interplay between metabolic dysregulation and the progression of liver disease.